Olfactory neuroblastoma--an unusual presentation.
Cackett
P
P
Tennent Institute of Ophthalmology, Gartnavel General Hospital, Glasgow, Scotland. pdcackett@hotmail.com
Weir
C
C
D000328:Adult; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000032:analysis; D004172:Diplopia / Q000175:diagnosis / Q000188:drug therapy; D018304:Esthesioneuroblastoma, Olfactory / Q000737:chemistry / Q000175:diagnosis* / Q000188:drug therapy; D005094:Exophthalmos / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D006801:Humans; D007069:Ifosfamide / Q000627:therapeutic use; D007262:Infusions, Intravenous; D008279:Magnetic Resonance Imaging; D009296:Nasal Cavity; D016900:Neurofilament Proteins / Q000032:analysis; D009669:Nose Neoplasms / Q000737:chemistry / Q000175:diagnosis* / Q000188:drug therapy; D010751:Phosphopyruvate Hydratase / Q000032:analysis; D016708:Synaptophysin / Q000032:analysis; D014786:Vision Disorders / Q000175:diagnosis / Q000188:drug therapy
D018906:Antineoplastic Agents, Alkylating; D014408:Biomarkers, Tumor; D016900:Neurofilament Proteins; D016708:Synaptophysin; D010751:Phosphopyruvate Hydratase; D007069:Ifosfamide